Literature DB >> 17631599

Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.

V Diehl1, M Fuchs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17631599     DOI： 10.1093/annonc/mdm297

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Authors:  Gerard Moulin-Romsee; Elif Hindié; Xavier Cuenca; Pauline Brice; Didier Decaudin; Myriam Bénamor; Josette Brière; Marcela Anitei; Jean-Emmanuel Filmont; David Sibon; Eric de Kerviler; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

2.  Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.

Authors:  D Azambuja; Y Natkunam; I Biasoli; I S Lossos; M W Anderson; J C Morais; N Spector
Journal:  Ann Oncol       Date:  2011-05-20       Impact factor: 32.976

3.  Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma.

Authors:  Denize Azambuja; Izidore S Lossos; Irene Biasoli; José Carlos Morais; Luciana Britto; Adriana Scheliga; Wolmar Pulcheri; Yasodha Natkunam; Nelson Spector
Journal:  Leuk Lymphoma       Date:  2009-11

4.  Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.

Authors:  Sara Aquino; Marino Clavio; Edoardo Rossi; Luana Vignolo; Maurizio Miglino; Mauro Spriano; Letizia Canepa; Gioacchino Catania; Ivana Pierri; Micaela Bergamaschi; Roberta Gonella; Carlo Marani; Omar Racchi; Marina Cavaliere; Riccardo Goretti; Federico Carbone; Andrea Bruzzone; Rodolfo Tassara; Angelo Michele Carella; Riccardo Ghio; Marco Gobbi
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

5.  Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.

Authors:  Sabine Kürzel; André-René Blaudszun; Lilly Stahl; Stephan Fricke; Mathias Hänel; Regina Herbst; Frank Kroschinsky; Josef Birkmann; Annette Hänel; Kerstin Schaefer-Eckart; Gerhard Ehninger; Friedrich Fiedler; Martin Bornhäuser
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-26       Impact factor: 4.322

6.  Bone marrow uptake of 18F-fluorodeoxyglucose in Hodgkin lymphoma without bone involvement: comparison between patients with and without B symptoms.

Authors:  Rômulo Hermeto Bueno do Vale; Daniela Andrade Ferraro; Paulo Schiavom Duarte; Giovana Carvalho; Marcos Santos Lima; George Barbério Coura Filho; Marcelo Tatit Sapienza; Carlos Alberto Buchpiguel
Journal:  Radiol Bras       Date:  2018 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.